NCT01597453

Brief Summary

NOR-SYS is a clinical research program about young ischemic stroke patients from 15 to 60 years. Patients, partners and the couple´s adult children who are at least 18 years old, are all invited to ultrasound examinations due to a standardized protocol. Parents of patients and partners are invited to return their answers of standardized questionnaires about clinical ischemic events such as stroke, angina or myocardial infarction or peripheral artery disease. Study inclusion time of patients and their families is 5 years. A biobank is build from samples from patients, partners and adult children. Clinical follow-ups for patients and partners are planned after 5, 10 and 15 years. Clinical follow-ups for adult children are planned after 10 and 20 years. Hypotheses: What do patients know about their parents clinical ischemic events? How much established pathology in arteries do we find by a standardized ultrasound protocol at the time of ischemic stroke at a young age? Differences concerning risk factors and ultrasound findings between patients and partners? Differences between children from families with several ischemic events among parents and grandparents vs. children from families without ischemic events? Biochemical markers related to ultrasound findings and artery disease.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,062

participants targeted

Target at P75+ for not_applicable

Timeline
57mo left

Started Sep 2010

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress77%
Sep 2010Dec 2030

Study Start

First participant enrolled

September 1, 2010

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

May 2, 2012

Completed
12 days until next milestone

First Posted

Study publicly available on registry

May 14, 2012

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2015

Completed
15.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2030

Expected
Last Updated

April 1, 2025

Status Verified

March 1, 2025

Enrollment Period

5 years

First QC Date

May 2, 2012

Last Update Submit

March 26, 2025

Conditions

Keywords

Young ischemic strokeFamiliesLong-term follow-up

Outcome Measures

Primary Outcomes (1)

  • All cause mortality

    Outcome measure is assessed every five years.

    15 years for patients and partners and 20 years for offspring

Secondary Outcomes (1)

  • Arterial events (recurrent stroke or transitory ischemic attack, myocardial infarction or angina, peripheral artery disease

    15 years for patients and partners and 20 years for offspring

Study Arms (1)

Lifestyle counseling

OTHER

There are no different arms, NOR-SYS is an observational study

Behavioral: Lifestyle counseling

Interventions

Ultrasound examinations of carotid arteries, aorta abdominalis, femoral arteries and lifestyle counseling

Also known as: NOR-SYS
Lifestyle counseling

Eligibility Criteria

Age15 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Documented ischemic stroke at age from 15 up to 60 years

You may not qualify if:

  • Stroke as end-of-life event among patients with cancer or other life-threatening disease
  • Stroke caused by trauma

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dep. of Neurology

Bergen, 5053, Norway

Location

Related Publications (7)

  • Jibril KA, Kuiper KJ, Nawaz B, Naess H, Fromm A, Oygarden H, Sand KM, Meijer R, Mohamed Ali A, Larsen TH, Bleie O, Skaar E, Waje-Andreassen U, Saeed S. Burden of Coronary Artery Disease as a Predictor of New Vascular Events and Mortality in Patients With Ischemic Stroke: Insights From the Norwegian Stroke in the Young Study. J Am Heart Assoc. 2025 Mar 18;14(6):e038899. doi: 10.1161/JAHA.124.038899. Epub 2025 Mar 13.

  • Oftedal A, Gerdts E, Waje-Andreassen U, Fromm A, Naess H, Linde A, Saeed S. Prevalence and covariates of uncontrolled hypertension in ischemic stroke survivors: the Norwegian stroke in the young study. Blood Press. 2018 Jun;27(3):173-180. doi: 10.1080/08037051.2018.1425827. Epub 2018 Jan 15.

  • Oygarden H, Fromm A, Sand KM, Kvistad CE, Eide GE, Thomassen L, Naess H, Waje-Andreassen U. A Family History of Stroke Is Associated with Increased Intima-Media Thickness in Young Ischemic Stroke - The Norwegian Stroke in the Young Study (NOR-SYS). PLoS One. 2016 Aug 9;11(8):e0159811. doi: 10.1371/journal.pone.0159811. eCollection 2016.

  • Oygarden H, Fromm A, Sand KM, Eide GE, Thomassen L, Naess H, Waje-Andreassen U. Stroke patients' knowledge about cardiovascular family history - the Norwegian Stroke in the Young Study (NOR-SYS). BMC Neurol. 2015 Mar 12;15:30. doi: 10.1186/s12883-015-0276-6.

  • Saeed S, Waje-Andreassen U, Fromm A, Oygarden H, Kokorina MV, Naess H, Gerdts E. Early vascular aging in young and middle-aged ischemic stroke patients: the Norwegian Stroke in the Young Study. PLoS One. 2014 Nov 18;9(11):e112814. doi: 10.1371/journal.pone.0112814. eCollection 2014.

  • Fromm A, Haaland OA, Naess H, Thomassen L, Waje-Andreassen U. Risk factors and their impact on carotid intima-media thickness in young and middle-aged ischemic stroke patients and controls: the Norwegian Stroke in the Young Study. BMC Res Notes. 2014 Mar 26;7:176. doi: 10.1186/1756-0500-7-176.

  • Fromm A, Thomassen L, Naess H, Meijer R, Eide GE, Krakenes J, Vedeler CA, Gerdts E, Larsen TH, Kuiper KK, Laxdal E, Russell D, Tatlisumak T, Waje-Andreassen U. The Norwegian Stroke in the Young Study (NOR-SYS): rationale and design. BMC Neurol. 2013 Jul 17;13:89. doi: 10.1186/1471-2377-13-89.

MeSH Terms

Conditions

DeathCarotid Artery DiseasesCardiovascular DiseasesPeripheral Arterial Disease

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesAtherosclerosisArteriosclerosisArterial Occlusive DiseasesPeripheral Vascular Diseases

Study Officials

  • Ulrike Waje-Andreassen, MD, PhD

    Haukeland UH

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: Inclusion was completed in 2015, and the 5-year follow-up phase was completed in july 2021. The planned 10-year follow-up has not been possible due to the covid pandemia. A final 15 year follow-up was originally planned, and would start in 2025.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 2, 2012

First Posted

May 14, 2012

Study Start

September 1, 2010

Primary Completion

August 31, 2015

Study Completion (Estimated)

December 31, 2030

Last Updated

April 1, 2025

Record last verified: 2025-03

Locations